Using aspirin to help women recover from severe preeclampsia after childbirth
Official title: Acetylsalicylic Acid for Postpartum Preeclampsia: A Pilot Randomized Trial
Run by MemorialCare Health System · NCT05924971 · Data updated 2026-11-12
This study tests if taking low-dose aspirin for a week after childbirth can help women recover faster from severe preeclampsia.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 86 (estimated) |
| Sponsor | MemorialCare Health System Academic / other |
| Locations | 1 site (Long Beach, California) |
| Status | Recruiting |
| Started | July 26, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 6, 2025 |
| Trial ID | NCT05924971 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women diagnosed with severe preeclampsia during delivery who are receiving care from the specified medical facilities.
✕Probably not a fit
Patients under 18 years old, those with chronic hypertension prior to pregnancy, or those with contraindications to aspirin will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of low-dose aspirin on the recovery of women who have experienced severe preeclampsia during childbirth. The hypothesis is that aspirin will reduce levels of a protein called sFlt-1, which is linked to the condition, and help normalize blood pressure more quickly. Participants will take aspirin for the first week postpartum to assess its impact on their recovery. The study aims to address the lack of therapies targeting the underlying causes of postpartum preeclampsia.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for women suffering from postpartum preeclampsia.
How similar studies have gone: While the approach of using aspirin in this context is novel, previous studies have shown aspirin's effectiveness in other pregnancy-related conditions, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preeclampsia with severe features diagnosed during delivery admission, as defined by ACOG criteria. * Pre- and postnatal care provided by the Long Beach Memorial Ob/Gyn resident or Maternal-Fetal Medicine clinic. Exclusion Criteria: * Patient age \<18 years old * Non-English or Non-Spanish speaking * Chronic hypertension diagnosed before 20 weeks' gestation * Known allergy, prior adverse reaction, or any medical condition in which aspirin is contraindicated (nasal polyps, gastric or duodenal ulcers, history of gastrointestinal bleeding, severe hepatic dysfunction) * Aspirin prescribed postpartum for any other medical condition * Bleeding disorder * Breastfeeding an infant with thrombocytopenia
Where it's running
-
Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach
Long Beach, California, United States Recruiting
Study contacts
- Principal investigator: Megan C Oakes, MD MSCI — Miller Children's and Women's Hospital, Long Beach/ MemorialCare Medical Center
- Study coordinator: Megan C Oakes, MD MSCI
- Email: moakes2@memorialcare.org
- Phone: 562-997-8510
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum Preeclampsia Care Using Point-of-Care Ultrasound and Diuretics
The study tests whether using bedside ultrasound to guide diuretic therapy can improve outcomes for adults with preeclampsia after delivery.
-
Effects of high-salt intake on women after preeclampsia
This study is testing how eating a lot of salt affects blood vessel health in women who had preeclampsia during pregnancy, to see if a medication can help improve their condition.
-
Using aspirin to reduce postpartum heart issues in women with preeclampsia
This study is testing if taking aspirin after childbirth can help women with preeclampsia and high Activin A levels have better heart function.
-
Low-dose aspirin for women with severe preeclampsia after delivery
This study is testing if giving low-dose aspirin to women with severe preeclampsia after childbirth can help improve their blood vessel function and make their condition better.
-
Nifedipine and Enalapril vs Nifedipine and Labetalol for Postpartum Hypertension
This study tests whether adding enalapril to nifedipine better controls postpartum hypertension than adding labetalol.
-
Postpartum Preeclampsia Early Detection and Treatment in Nepal: A Pilot Study
This pilot study tests whether using sFlt-1/PlGF biomarker testing before delivery can predict postpartum preeclampsia and whether an early monitoring and treatment bundle helps high-risk, postpartum patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.